FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

225411000001101: Doxazosin 2mg tablets (Kent Pharma (UK) Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1863801000001116 Doxazosin 2mg tablets (Kent Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1863821000001111 Doxazosin 2mg tablets (Kent Pharma (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Doxazosin 2mg tablets (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Kent Pharma (UK) Ltd) Is a Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Kent Pharma (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Kent Pharma (UK) Ltd) Has active ingredient Doxazosin mesilate false Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Kent Pharma (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Kent Pharma (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Kent Pharma (UK) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Doxazosin true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Kent Pharma (UK) Ltd) Has specific active ingredient Doxazosin mesilate true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Kent Pharma (UK) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Kent Pharma (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Kent Pharma (UK) Ltd) Has basis of strength substance Doxazosin true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Doxazosin 2mg tablets (Kent Pharma (UK) Ltd) 28 tablet Is pack of False Doxazosin 2mg tablets (Kent Pharma (UK) Ltd) Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets (Kent Pharma (UK) Ltd) 28 tablet Has AMP True Doxazosin 2mg tablets (Kent Pharma (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start